XML 167 R171.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Guarantor Condensed Consolidating Financial Information - Condensed Consolidating Statements of Comprehensive Income (Loss) (Details) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Condensed Income Statements, Captions [Line Items]                      
Net sales $ 1,353 $ 1,390 $ 1,408 $ 1,376 $ 1,464 $ 1,628 $ 1,816 $ 1,730 $ 5,526 $ 6,638 $ 6,183
Cost of goods sold 1,203 1,096 1,085 1,080 1,064 1,151 1,259 1,193 4,463 4,667 4,438
Gross profit                 1,063 1,971 1,745
Selling, general, and administrative expense                 548 657 626
Research and development expense                 80 82 81
Restructuring, asset-related, and other charges                 87 49 57
Total other operating expenses                 715 788 764
Equity in earnings of affiliates                 29 43 33
Equity in earnings (loss) of subsidiaries                 0 0 0
Interest (expense) income, net                 (208) (195) (214)
Loss on extinguishment of debt                 0 (38) (1)
Intercompany interest income (expense), net                 0 0 0
Other income (expense), net                 (293) 162 113
(Loss) income before income taxes (454) 91 133 107 182 269 323 381 (124) 1,155 912
(Benefit from) provision for income taxes                 (72) 159 165
Net (loss) income (317) 76 96 94 142 275 282 297 (52) 996 747
Less: Net income attributable to non-controlling interests                 0 1 1
Net (loss) income attributable to Chemours $ (317) $ 76 $ 96 $ 94 $ 142 $ 275 $ 281 $ 297 (52) 995 746
Comprehensive income (loss) attributable to Chemours                 163 873 881
Eliminations and Adjustments [Member]                      
Condensed Income Statements, Captions [Line Items]                      
Net sales                 (1,487) (1,820) (1,734)
Cost of goods sold                 (1,487) (1,825) (1,691)
Gross profit                 0 5 (43)
Selling, general, and administrative expense                 (18) (24) (38)
Research and development expense                 0 0 0
Restructuring, asset-related, and other charges                 0 0 0
Total other operating expenses                 (18) (24) (38)
Equity in earnings of affiliates                 0 0 0
Equity in earnings (loss) of subsidiaries                 (70) (1,157) (849)
Interest (expense) income, net                 0 0 0
Loss on extinguishment of debt                   0 0
Intercompany interest income (expense), net                 0 0 0
Other income (expense), net                 (19) (22) (34)
(Loss) income before income taxes                 (71) (1,150) (888)
(Benefit from) provision for income taxes                 (1) 0 (4)
Net (loss) income                 (70) (1,150) (884)
Less: Net income attributable to non-controlling interests                 0 0 0
Net (loss) income attributable to Chemours                 (70) (1,150) (884)
Comprehensive income (loss) attributable to Chemours                 (270) (1,012) (1,081)
Parent Issuer [Member] | Reportable Legal Entities [Member]                      
Condensed Income Statements, Captions [Line Items]                      
Net sales                 0 0 0
Cost of goods sold                 0 0 0
Gross profit                 0 0 0
Selling, general, and administrative expense                 19 33 36
Research and development expense                 0 0 0
Restructuring, asset-related, and other charges                 0 0 0
Total other operating expenses                 19 33 36
Equity in earnings of affiliates                 0 0 0
Equity in earnings (loss) of subsidiaries                 73 1,155 849
Interest (expense) income, net                 (209) (210) (220)
Loss on extinguishment of debt                   (38) (1)
Intercompany interest income (expense), net                 41 47 64
Other income (expense), net                 21 25 29
(Loss) income before income taxes                 (93) 946 685
(Benefit from) provision for income taxes                 (41) (50) (62)
Net (loss) income                 (52) 996 747
Less: Net income attributable to non-controlling interests                 0 0 0
Net (loss) income attributable to Chemours                 (52) 996 747
Comprehensive income (loss) attributable to Chemours                 163 873 881
Guarantor Subsidiaries [Member] | Reportable Legal Entities [Member]                      
Condensed Income Statements, Captions [Line Items]                      
Net sales                 3,357 3,974 3,887
Cost of goods sold                 3,068 3,112 3,084
Gross profit                 289 862 803
Selling, general, and administrative expense                 406 485 449
Research and development expense                 73 76 74
Restructuring, asset-related, and other charges                 74 46 56
Total other operating expenses                 553 607 579
Equity in earnings of affiliates                 0 0 0
Equity in earnings (loss) of subsidiaries                 (3) 2 0
Interest (expense) income, net                 0 5 3
Loss on extinguishment of debt                   0 0
Intercompany interest income (expense), net                 16 10 0
Other income (expense), net                 122 199 139
(Loss) income before income taxes                 (129) 471 366
(Benefit from) provision for income taxes                 (28) 98 117
Net (loss) income                 (101) 373 249
Less: Net income attributable to non-controlling interests                 0 0 0
Net (loss) income attributable to Chemours                 (101) 373 249
Comprehensive income (loss) attributable to Chemours                 (101) 375 253
Non-Guarantor Subsidiaries [Member] | Reportable Legal Entities [Member]                      
Condensed Income Statements, Captions [Line Items]                      
Net sales                 3,656 4,484 4,030
Cost of goods sold                 2,882 3,380 3,045
Gross profit                 774 1,104 985
Selling, general, and administrative expense                 141 163 179
Research and development expense                 7 6 7
Restructuring, asset-related, and other charges                 13 3 1
Total other operating expenses                 161 172 187
Equity in earnings of affiliates                 29 43 33
Equity in earnings (loss) of subsidiaries                 0 0 0
Interest (expense) income, net                 1 10 3
Loss on extinguishment of debt                   0 0
Intercompany interest income (expense), net                 (57) (57) (64)
Other income (expense), net                 (417) (40) (21)
(Loss) income before income taxes                 169 888 749
(Benefit from) provision for income taxes                 (2) 111 114
Net (loss) income                 171 777 635
Less: Net income attributable to non-controlling interests                 0 1 1
Net (loss) income attributable to Chemours                 171 776 634
Comprehensive income (loss) attributable to Chemours                 $ 371 $ 637 $ 828